NCT07041021 Intraoperative Fluid Management Guided by Internal Jugular Vein on Postoperative Complications in Abdominal Surgeries
| NCT ID | NCT07041021 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Suez Canal University |
| Condition | Postoperative Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-07-15 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2025-07-15 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the role of respiratory variation in the internal jugular vein as a tool for intraoperative fluid management during abdominal surgeries under general anesthesia. The purpose of this clinical trial is to reduce postoperative complications and improve patient outcomes through proper intraoperative fluid management. The main question it aims to answer is: Can intraoperative fluid management guided by the respiratory variation of the internal jugular vein during abdominal surgeries reduce postoperative complications? Research Hypothesis (Alternative Hypothesis): We hypothesize that fluid management guided by the respiratory variation of the internal jugular vein during abdominal surgeries can reduce postoperative complications. The patients will be divided into two groups and randomized to receive either intraoperative fluid therapy guided by the respiratory variation of the internal jugular vein or standard fluid therapy. Postoperative complications, length of hospital stay, total amount of fluid administered intraoperatively, use of vasopressors in both groups, and incidence of hypotensive episodes will be recorded.
Eligibility Criteria
Inclusion Criteria: 1. Patients' American Society of Anesthesiologists physical status (ASA) is I and II. 2. The target age group is 20 to 70 years old. 3. Patients scheduled for abdominal surgery under general anesthesia with normal renal function. Exclusion Criteria: 1. Refusal of the procedure or participation in the study. 2. Coagulopathy. 3. Pre-existing cardiac, renal, and respiratory diseases. 4-Internal jugular vein thrombosis
Contact & Investigator
Mohammad E Salama, MD
PRINCIPAL INVESTIGATOR
Suez canal university hospitals
Frequently Asked Questions
Who can join the NCT07041021 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Postoperative Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07041021 currently recruiting?
Yes, NCT07041021 is actively recruiting participants. Contact the research team at MohammadElhossieny88@med.suez.edu.eg for enrollment information.
Where is the NCT07041021 trial being conducted?
This trial is being conducted at Ismailia, Egypt, Ismailia, Egypt.
Who is sponsoring the NCT07041021 clinical trial?
NCT07041021 is sponsored by Suez Canal University. The principal investigator is Mohammad E Salama, MD at Suez canal university hospitals. The trial plans to enroll 84 participants.